Related references
Note: Only part of the references are listed.P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment
Abdel Kareem Azab et al.
BLOOD (2012)
Treatment strategies in relapsed and refractory multiple myeloma: a focus on drug sequencing and 'retreatment' approaches in the era of novel agents
B. Mohty et al.
LEUKEMIA (2012)
Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow
Alexander Zarbock et al.
BLOOD (2011)
A therapeutic role for targeting c-Myc/Hif-1-dependent signaling pathways
Klaus Podar et al.
CELL CYCLE (2010)
Protein kinase networks regulating glucocorticoid-induced apoptosis of hematopoietic cancer cells: fundamental aspects and practical considerations
Shlomit Kfir-Erenfeld et al.
LEUKEMIA & LYMPHOMA (2010)
Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis
Yuhuan Zheng et al.
BLOOD (2009)
Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic Target
Dharminder Chauhan et al.
CANCER CELL (2009)
Constitutively lower expressions of CD54 on primary myeloma cells and their different localizations in bone marrow
Mohd S. Iqbal et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Silencing cAMP-response Element-binding Protein (CREB) Identifies CYR61 as a Tumor Suppressor Gene in Melanoma
Andrey S. Dobroff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Bone marrow microenvironment and the identification of new targets for myeloma therapy
K. Podar et al.
LEUKEMIA (2009)
Clinical challenges associated with bortezomib therapy in multiple myeloma and Waldenstroms Macroglobulinemia
Jacob P. Laubach et al.
LEUKEMIA & LYMPHOMA (2009)
Bioinformatics construction of the human cell surfaceome
J. P. C. da Cunha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Treatment of Relapsed/Refractory Multiple Myeloma
Efstathios Kastritis et al.
SEMINARS IN HEMATOLOGY (2009)
Modulation of tumor associated macrophages in solid tumors
Trevor Lucas
Frontiers in Bioscience-Landmark (2008)
Thalidomide Resistance Is Based on the Capacity of the Glutathione-Dependent Antioxidant Defense
Juergen Knobloch et al.
MOLECULAR PHARMACEUTICS (2008)
New targets and treatments in multiple myeloma: Src family kinases as central regulators of disease progression
Morie A. Gertz
LEUKEMIA & LYMPHOMA (2008)
Human C-reactive protein binds activating Fcγ receptors and protects myeloma tumor cells from apoptosis
Jing Yang et al.
CANCER CELL (2007)
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
Teru Hideshima et al.
NATURE REVIEWS CANCER (2007)
Enhancement of clonogenicity of human multiple myeloma by dendritic cells
Anjli Kukreja et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells
T Ito et al.
BLOOD (2006)
Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis
J Condeelis et al.
CELL (2006)
Arterial macrophages and regenerating endothelial cells express P-selectin in atherosclerosis-prone apolipoprotein E-deficient mice
GH Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Cancer and the microenvironment: Myeloma-osteoclast interactions as a model
S Yaccoby et al.
CANCER RESEARCH (2004)
Peritoneal macrophages express both P-selectin and PSGL-1
B Tchernychev et al.
JOURNAL OF CELL BIOLOGY (2003)
Map kinase signaling pathways and hematologic malignancies
LC Platanias
BLOOD (2003)
Share Paper
